Insider Buy/Sell Ratio - Canada Drug Manufacturers, Director : 2 (As of 2025-01-01)
Basic Info
The Insider Buy/Sell Ratio for Directors in Canada's Drug Manufacturing sector measures the frequency of stock purchases versus sales by directors within this industry, providing insights into their confidence in the sector's future. Calculated monthly but updated daily for the most recent data, this ratio is determined by dividing the number of buy transactions by the number of sell transactions executed by directors over a specified period. A higher ratio suggests directors are optimistic about the industry's prospects, indicating potential growth or undervaluation.
Insider Buy/Sell Ratio - Canada Drug Manufacturers, Director was 2 as of 2025-01-01, according to GuruFocus. Historically, Insider Buy/Sell Ratio - Canada Drug Manufacturers, Director reached a record high of 64 and a record low of 0.25, the median value is 4.1. Typical value range is from 0.25 to 15.34. The Year-Over-Year growth is -79.91%. GuruFocus provides the current actual value, an historical data chart and related indicators for Insider Buy/Sell Ratio - Canada Drug Manufacturers, Director - last updated on 2025-01-01.
| Category | Market Trend |
| Region | CAN |
| Source | GuruFocus |
Stats
| Name | Value | ||
|---|---|---|---|
| Last Value | 2 | ||
| Latest Period | 2025-01-01 | ||
| Long Term Average | 6.53 | ||
| Average Annualized Growth Rate | +9.14% | ||
| Value from 1 year ago | 10 | ||
| Change from 1 year ago | -80% | ||
| Frequency | Daily | ||
| Unit |
Related Indicators
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
